» Articles » PMID: 36211451

Signature of Gene Expression Profile of Liver Sinusoidal Endothelial Cells in Nonalcoholic Steatohepatitis

Overview
Specialty Cell Biology
Date 2022 Oct 10
PMID 36211451
Authors
Affiliations
Soon will be listed here.
Abstract

There has been emerging evidence that liver sinusoidal endothelial cells (LSECs) play an important role in the pathogenesis of nonalcoholic steatohepatitis (NASH). This study aims to figure out the signature of the gene expression profile of LSECs in NASH and to explore potential biomarkers related to damaged LSECs in NASH. Animal experiments were performed to demonstrate the significant structural damage of LSECs in the NASH model. To further understand the functional changes of these damaged LSECs in NASH, we used the public GEO database that contained microarray data for the gene expression of LSECs in NASH and normal mouse liver. Differentially expressed genes (DEGs) were analyzed, and further Gene Ontology (GO) enrichment analysis was performed to understand the functional changes. The hub genes were then identified and validated external GEO databases. There was significant structural damage to LSECs in the NASH model, accompanied by remarkable functional changes of LSECs with 174 DEGs (156 upregulated and 18 downregulated genes). The functions of these DEGs were mainly enriched in the inflammatory reactions and immune responses. Nine specifically expressed hub genes were identified. Among them, CCL4 and ITGAX showed the most significant correlation with NASH, with AUROC of 0.77 and 0.86, respectively. The protein-protein interaction network, mRNA-miRNA interaction network, and ceRNA network were further predicted. LSECs show significant structural damage and functional changes in NASH. The LSEC-related DEGs, such as CCL4 and ITGAX, might be promising biomarkers as well as potential treatment targets for NASH.

References
1.
Knolle P, Schmitt E, Jin S, Germann T, Duchmann R, Hegenbarth S . Induction of cytokine production in naive CD4(+) T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells. Gastroenterology. 1999; 116(6):1428-40. DOI: 10.1016/s0016-5085(99)70508-1. View

2.
Kleiner D, Brunt E, Wilson L, Behling C, Guy C, Contos M . Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease. JAMA Netw Open. 2019; 2(10):e1912565. PMC: 6784786. DOI: 10.1001/jamanetworkopen.2019.12565. View

3.
Younossi Z, Koenig A, Abdelatif D, Fazel Y, Henry L, Wymer M . Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2015; 64(1):73-84. DOI: 10.1002/hep.28431. View

4.
Kita Y, Takamura T, Misu H, Ota T, Kurita S, Takeshita Y . Metformin prevents and reverses inflammation in a non-diabetic mouse model of nonalcoholic steatohepatitis. PLoS One. 2012; 7(9):e43056. PMC: 3445596. DOI: 10.1371/journal.pone.0043056. View

5.
Cai J, Zhang X, Li H . The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis. Hepatology. 2019; 70(3):1026-1037. DOI: 10.1002/hep.30506. View